Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media, as well as to allow video information to be shared for both marketing, analytics and editorial purposes.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

You are viewing the site in preview mode

Skip to main content
BMC is moving to Springer Nature Link. Visit this journal in its new home.
Fig. 6 | Journal of Translational Medicine

Fig. 6

From: Integrated omics profiling reveals systemic dysregulation and potential biomarkers in the blood of patients with neuromyelitis optica spectrum disorders

Fig. 6

Difference in peripheral features between different clinical subgroups. Bar plot of significantly differential expressed cytokines (P < 0.05) between EDSS-H (n = 16) and EDSS-L (n = 24) (A), between AQP4-L (n = 17) and AQP4-H (n = 23) (B, between T2 (n = 16) and T1 (n = 24) (C), between HR (n = 24) and LR (n = 16) (D), between Recurrence (n = 18) and First episode (n = 22) (E). F The serum level of FAP in first episode (n = 20) and recurrence (n = 20) of NMOSD, Student’s t-test, *P < 0.05. G The serum level of FAP in T1 (< 3 years) (n = 27) and T2 (≥ 3 years) (n = 13) of NMOSD, Student’s t-test, *P < 0.05

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us